-+ 0.00%
-+ 0.00%
-+ 0.00%

KADIMA NEUROPSYCHIATRY INSTITUTE FILES SUIT AGAINST NRX PHARMACEUTICALS (NASDAQ: NRXP), ALLEGING BREACH OF CONTRACT AND MISREPRESENTATION IN CONNECTION WITH ACQUISITION

Reuters·06/24/2026 17:19:05

Please log in to view news